Evidence map›Paper›PMID 36261007›Full record

ArticleCell reports2022

Genomic landscape of drug response reveals mediators of anthelmintic resistance.

Stephen R Doyle, Roz Laing, David Bartley, Alison Morrison, Nancy Holroyd, Kirsty Maitland, Alistair Antonopoulos, Umer Chaudhry, Ilona Flis, Sue Howell and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Frontiers in pharmacology · 2023
    Pooled it
  2. Article
  3. Evolutionary and epidemiological considerations for anthelmintic treatments in ruminant livestock.International journal for parasitology. Drugs and drug resistance · 2026
    Article
  4. Article
  5. Article
  6. Chalcone andMolecules (Basel, Switzerland) · 2026
    Article
  7. P-glycoproteins and amphids: a two-stage trajectory of ivermectin resistance in Caenorhabditis elegans.International journal for parasitology. Drugs and drug resistance · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Next-generation molecular tools in veterinary parasitology: advances, challenges, and perspectives in the diagnosis of emerging parasites.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Stephen R DoyleWellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: stephen.doyle@sanger.ac.uk.
Roz LaingInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK. Electronic address: rosalind.laing@glasgow.ac.uk.
David BartleyMoredun Research Institute, Penicuik, Midlothian EH26 0PZ, UK.
Alison MorrisonMoredun Research Institute, Penicuik, Midlothian EH26 0PZ, UK.
Nancy HolroydWellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
Kirsty MaitlandInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Alistair AntonopoulosInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Umer ChaudhryRoyal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh EH25 9RG, UK.
Ilona FlisInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Sue HowellDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Jennifer McIntyreInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
John S GilleardDepartment of Comparative Biology and Experimental Medicine, Host-Parasite Interactions Program, Faculty of Veterinary Medicine, University of Calgary, Calgary T2N 1N4, Canada.
Andy TaitInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Barbara MableInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Ray KaplanDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Neil SargisonRoyal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh EH25 9RG, UK.
Collette BrittonInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Matthew BerrimanWellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
Eileen DevaneyInstitute of Biodiversity Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
James A CottonWellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
University of Glasgow · GBWellcome Sanger Institute · GBMoredun Research Institute · GBUniversity of Edinburgh · GBUniversity of Georgia · USUniversity of Calgary · CA

Funding

Biotechnology and Biological Sciences Research Council BB/M003949Medical Research Council MR/T020733/1Wellcome TrustWellcome Trust 206194Wellcome Trust 208390/Z/17/ZWellcome Trust 216614/Z/19/Z
6 · The paper itself

Abstract

Like other pathogens, parasitic helminths can rapidly evolve resistance to drug treatment. Understanding the genetic basis of anthelmintic drug resistance in parasitic nematodes is key to tracking its spread and improving the efficacy and sustainability of parasite control. Here, we use an in vivo genetic cross between drug-susceptible and multi-drug-resistant strains of Haemonchus contortus in a natural host-parasite system to simultaneously map resistance loci for the three major classes of anthelmintics. This approach identifies new alleles for resistance to benzimidazoles and levamisole and implicates the transcription factor cky-1 in ivermectin resistance. This gene is within a locus under selection in ivermectin-resistant populations worldwide; expression analyses and functional validation using knockdown experiments support that cky-1 is associated with ivermectin survival. Our work demonstrates the feasibility of high-resolution forward genetics in a parasitic nematode and identifies variants for the development of molecular diagnostics to combat drug resistance in the field.

Indexed as

AnthelminticsIvermectinBenzimidazolesDrug ResistanceGenomicsLevamisoleTranscription FactorsAnthelminticsBenzimidazolesIvermectinLevamisoleTranscription Factorsanthelmintic resistancebenzimidazolecky-1CP: MicrobiologyCP: Molecular biologyforward geneticsgenetic crossgenome-wide associationHaemonchus contortushelminthivermectinlevamisole

Identifiers

PMID36261007
PMCPMC9597552
OpenAlexW4306746309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.